MedTrace Logo

Observational Study of Treated and Untreated Acute and Early HIV-1 Infection

NCT00219934 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 399

Last updated 2012-02-17

No results posted yet for this study

Summary

Group A: Long-term follow-up is needed for subjects identified as acute or early in the course of HIV-1 infection, independent of decisions regarding therapy with highly active anti-retroviral therapy (HAART).

Group B: This protocol will also be offered to subjects who were diagnosed with acute HIV-1 infection in the past and have been participating in an ADARC/Rockefeller University Hospital treatment protocol for acute HIV-1 infection, and currently have a viral load consistently less than 50 copies/ml on current treatment (Group B)

Conditions

  • HIV Infections

Interventions

DRUG

Antiretroviral therapy

HAART therapy

Sponsors & Collaborators

  • Aaron Diamond AIDS Research Center

    collaborator OTHER

  • Rockefeller University

    lead OTHER

Principal Investigators

  • Martin Markowitz, MD · Rockefeller University

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-02-28
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00219934 on ClinicalTrials.gov